University of North Carolina at Chapel Hill, School of Medicine

Chapel Hill, North Carolina 27599-7584

3 studies enrolling now · 13 studies all time

What they study most

Alcohol Dependence, Alzheimer Disease, Angelman Syndrome, Cancer, Cardiovascular Diseases, Chronic Pain, Compensated Cirrhosis, Depression, Depression, Postpartum, Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate

Studies at this site

• BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome. — Recruiting now
• Global Paradise System US Post Approval Study — Recruiting now
• MAGIC Study: More Access to Group Integrative Care — Enrolling by invitation
• Implement and Test Visual Consent Template and Process — Stopped early
• A Study of the ReCor Medical Paradise System in Clinical Hypertension — Running, not enrolling
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis — Completed
• Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model — Completed
• Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause" — Completed
• Peanut Epicutaneous Phase II Immunotherapy Clinical Trial — Completed
• Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma — Completed
• An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma — Completed
• Efficacy and Tolerability of Baclofen for Alcohol Dependence — Completed